Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
Holding AU:PTX?
Track your performance easily

Prescient Therapeutics Limited (PTX) Share Price & Analysis

9 Followers

PTX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.03%97.97%
― Other Institutional Investors
97.97% Public Companies and
Individual Investors

PTX FAQ

What was Prescient Therapeutics Limited’s price range in the past 12 months?
Prescient Therapeutics Limited lowest share price was AU$0.04 and its highest was AU$0.10 in the past 12 months.
    What is Prescient Therapeutics Limited’s market cap?
    Currently, no data Available
    When is Prescient Therapeutics Limited’s upcoming earnings report date?
    Prescient Therapeutics Limited’s upcoming earnings report date is Feb 21, 2025 which is in 100 days.
      How were Prescient Therapeutics Limited’s earnings last quarter?
      Prescient Therapeutics Limited released its earnings results on Aug 26, 2024. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
        Is Prescient Therapeutics Limited overvalued?
        According to Wall Street analysts Prescient Therapeutics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Prescient Therapeutics Limited pay dividends?
          Prescient Therapeutics Limited does not currently pay dividends.
          What is Prescient Therapeutics Limited’s EPS estimate?
          Prescient Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Prescient Therapeutics Limited have?
          Prescient Therapeutics Limited has 805,319,760 shares outstanding.
            What happened to Prescient Therapeutics Limited’s price movement after its last earnings report?
            Prescient Therapeutics Limited reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20%.
              Which hedge fund is a major shareholder of Prescient Therapeutics Limited?
              Currently, no hedge funds are holding shares in AU:PTX
              ---

              Company Description

              Prescient Therapeutics Limited

              Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Race Oncology Ltd.
              Advaxis
              Verastem
              Akari Therapeutics
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis